Comparison of vessel dilator and long-acting natriuretic peptide in the treatment of congestive heart failure

Background Long-acting natriuretic peptide (LANP; proANF 1-30) and vessel dilator (proANF 31-67) enhance sodium and water excretion in healthy human beings. The current investigation was designed to compare the beneficial effects of LANP and vessel dilator in persons with congestive heart failure (C...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American heart journal 1999-10, Vol.138 (4), p.625-632
Hauptverfasser:	Vesely, David L., Dietz, John R., Parks, James R., Antwi, Ernest A., Overton, Rose M., McCormick, Michael T., Cintron, Guillermo, Schocken, Douglas D.
Format:	Artikel
Sprache:	eng
Schlagworte:	Atrial Natriuretic Factor - administration & dosage Atrial Natriuretic Factor - therapeutic use Biological and medical sciences Cardiovascular system Heart Failure - drug therapy Heart Failure - physiopathology Humans Infusions, Intravenous Male Medical sciences Middle Aged Natriuresis - drug effects Osmolar Concentration Peptide Fragments - administration & dosage Peptide Fragments - therapeutic use Pharmacology. Drug treatments Protein Precursors - administration & dosage Protein Precursors - therapeutic use Time Factors Vasodilator agents. Cerebral vasodilators
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!